These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27281102)

  • 1. Bleeding events associated with fibrinolytic therapy and primary percutaneous coronary intervention in patients with STEMI: A systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Janoo G; Chen MH
    Medicine (Baltimore); 2016 Jun; 95(23):e3877. PubMed ID: 27281102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
    Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.
    Roule V; Ardouin P; Blanchart K; Lemaitre A; Wain-Hobson J; Legallois D; Alexandre J; Sabatier R; Milliez P; Beygui F
    Crit Care; 2016 Nov; 20(1):359. PubMed ID: 27814743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
    Van de Werf F; Ristić AD; Averkov OV; Arias-Mendoza A; Lambert Y; Kerr Saraiva JF; Sepulveda P; Rosell-Ortiz F; French JK; Musić LB; Vandenberghe K; Bogaerts K; Westerhout CM; Pagès A; Danays T; Bainey KR; Sinnaeve P; Goldstein P; Welsh RC; Armstrong PW;
    Circulation; 2023 Aug; 148(9):753-764. PubMed ID: 37439219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Reperfusion Strategies for ST-Segment-Elevation Myocardial Infarction: A Multivariate Network Meta-analysis.
    Fazel R; Joseph TI; Sankardas MA; Pinto DS; Yeh RW; Kumbhani DJ; Nallamothu BK
    J Am Heart Assoc; 2020 Jun; 9(12):e015186. PubMed ID: 32500800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry.
    Bainey KR; Armstrong PW; Zheng Y; Brass N; Tyrrell BD; Leung R; Westerhout CM; Welsh RC
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e008059. PubMed ID: 31607152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Solhpour A; Chang KW; Arain SA; Balan P; Zhao Y; Loghin C; McCarthy JJ; Vernon Anderson H; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):709-715. PubMed ID: 27028120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-Analysis Comparing Primary Percutaneous Coronary Intervention Versus Pharmacoinvasive Therapy in Transfer Patients with ST-Elevation Myocardial Infarction.
    Siddiqi TJ; Usman MS; Khan MS; Sreenivasan J; Kassas I; Riaz H; Raza S; Deo SV; Sharif H; Kalra A; Yadav N
    Am J Cardiol; 2018 Aug; 122(4):542-547. PubMed ID: 30205885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry.
    Hira RS; Bhatt DL; Fonarow GC; Heidenreich PA; Ju C; Virani SS; Bozkurt B; Petersen LA; Hernandez AF; Schwamm LH; Eapen ZJ; Albert MA; Liang L; Matsouaka RA; Peterson ED; Jneid H
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing mortality between fibrinolysis and primary percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis of 27 randomized-controlled trials including 11 429 patients.
    Yanamala CM; Bundhun PK; Ahmed A
    Coron Artery Dis; 2017 Jun; 28(4):315-325. PubMed ID: 28362665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.
    Peiyuan H; Jingang Y; Haiyan X; Xiaojin G; Ying X; Yuan W; Wei L; Yang W; Xinran T; Ruohua Y; Chen J; Lei S; Xuan Z; Rui F; Yunqing Y; Qiuting D; Hui S; Xinxin Y; Runlin G; Yuejin Y;
    PLoS One; 2016; 11(11):e0165672. PubMed ID: 27812152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in-hospital outcomes with low-dose fibrinolytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Bhatt NS; Solhpour A; Balan P; Barekatain A; McCarthy JJ; Sdringola S; Denktas AE; Smalling RW; Anderson HV
    Am J Cardiol; 2013 Jun; 111(11):1576-9. PubMed ID: 23490028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network).
    Siontis KC; Barsness GW; Lennon RJ; Holmen JL; Wright RS; Bell MR; Gersh BJ
    Am J Cardiol; 2016 Jun; 117(12):1904-10. PubMed ID: 27131614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ischaemic postconditioning on outcomes of patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention: a meta-analysis.
    Xing Z; Tang L; Huang J; Peng X; Hu X
    BMJ Open; 2019 Mar; 9(3):e022509. PubMed ID: 30904835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Trends of Reperfusion Strategies and Hospital Mortality for Patients With STEMI in Percutaneous Coronary Intervention-Capable Hospitals.
    Tran DT; Welsh RC; Ohinmaa A; Thanh NX; Kaul P
    Can J Cardiol; 2017 Apr; 33(4):485-492. PubMed ID: 28256426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate versus deferred percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.
    Li W; He W; Zhou Y; Guo Y
    PLoS One; 2020; 15(7):e0234655. PubMed ID: 32614851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes of Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study from Mexico City.
    Arias-Mendoza A; Gopar-Nieto R; Juarez-Tolen J; Ordóñez-Olvera JC; Gonzalez-Pacheco H; Briseño-De la Cruz JL; Sierra-Lara Martinez D; Mendoza-García S; Altamirano-Castillo A; Montañez-Orozco A; Arzate-Ramirez A; Baeza-Herrera LA; Ortega-Hernandez JA; Miranda-Cerda G; Cruz-Martinez JE; Baranda-Tovar FM; Zabal-Cerdeira C; Araiza-Garaygordobil D
    Am J Cardiol; 2024 May; 218():7-15. PubMed ID: 38402926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.